Melatonin-Tamoxifen Conjugate (compound 16c) is an anticancer drug conjugate composed of Melatonin (HY-B0075) and Tamoxifen (HY-13757A), which is a potent antagonist of ERalpha (IC50=863 nM). Melatonin-Tamoxifen Conjugate binds to MLT receptor (Ki=3.1 nM) and promotes beta-arrestin (EC50=914 nM) and ERK activation (EC50=98 nM) in cells expressing hMT1 receptor. Melatonin-Tamoxifen Conjugate against several common cell lines MCF-7, MDA-MB-231, and HT-1080 with IC50s of 6.8 µM, 6.4 µM, and 1.7 µM, respectively.
Molecular Weight:
742.99
Formula:
C47H58N4O4
Target:
Melatonin Receptor
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
